ES2052825T3 - Derivados de cicloalquiltiazol. - Google Patents

Derivados de cicloalquiltiazol.

Info

Publication number
ES2052825T3
ES2052825T3 ES89112455T ES89112455T ES2052825T3 ES 2052825 T3 ES2052825 T3 ES 2052825T3 ES 89112455 T ES89112455 T ES 89112455T ES 89112455 T ES89112455 T ES 89112455T ES 2052825 T3 ES2052825 T3 ES 2052825T3
Authority
ES
Spain
Prior art keywords
lower alkyl
substituted
hydrogen
different
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89112455T
Other languages
English (en)
Inventor
George Francis Field
John Raymond Vermeulen
William Joseph Zally
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/366,097 external-priority patent/US5001140A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2052825T3 publication Critical patent/ES2052825T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LOS COMPUESTOS DE LA FORMULA GENERAL EN DONDE R ES HIDROGENO O ALQUILO INFERIOR, R1,R2,R3 Y R4, SON DE FORMA INDEPENDIENTE, HIDROGENO, ALQUILO INFERIOR, ALQUENILO INFERIOR, C3-6-CICLOALQUILO O UN GRUPO FENILO, EL CUAL ES NO SUBSTITUIDO O SUBSTITUIDO POR HASTA 3 SUBSTITUYENTES SELECCIONADOS INDEPENDIENTEMENTE DE ENTRE ALQUILO INFERIOR, ALCOXILO INFERIOR O HALOGENO, O R1 Y R2 SE UNEN JUNTOS AL ATOMO DE CARBONO, PARA LO QUE ELLOS ESTAN UNIDOS SIENDO UN GRUPO C2-5-ALQUILENO, EL CUAL ES NO SUBSTITUIDO O SUBSTITUIDO POR ALQUILO INFERIOR, Y N ES UN ENTERO DE 0 A 3, Y, CUANDO R1 ES DIFERENTE DE R2 Y/O R3 ES DIFERENTE DE R4, ENANTIOMEROS, DIASTEREOISOMEROS, Y SALES O ESTERES RACEMICOS DE ELLOS Y, CUANDO R ES HIDROGENO, SALES DE ELLOS CON BASES FARMACEUTICAMENTE ACEPTABLES SE EMPLEAN COMO AGENTES BRONCOPULMONARES, EN EL ALIVIO DEL ASMA Y REACCIONES ALERGICAS
ES89112455T 1988-07-15 1989-07-07 Derivados de cicloalquiltiazol. Expired - Lifetime ES2052825T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22611288A 1988-07-15 1988-07-15
US33904689A 1989-04-17 1989-04-17
US07/366,097 US5001140A (en) 1989-04-17 1989-06-13 Cycloalkylthiazoles

Publications (1)

Publication Number Publication Date
ES2052825T3 true ES2052825T3 (es) 1994-07-16

Family

ID=27397563

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89112455T Expired - Lifetime ES2052825T3 (es) 1988-07-15 1989-07-07 Derivados de cicloalquiltiazol.

Country Status (21)

Country Link
EP (1) EP0355353B1 (es)
JP (1) JPH0737454B2 (es)
KR (1) KR960010352B1 (es)
AR (1) AR247737A1 (es)
AU (1) AU626308B2 (es)
BG (1) BG60765B2 (es)
CA (1) CA1333906C (es)
CS (1) CS417291A3 (es)
DE (1) DE68913856T2 (es)
DK (1) DK350989A (es)
ES (1) ES2052825T3 (es)
FI (1) FI93953C (es)
HU (2) HU203087B (es)
IE (1) IE64011B1 (es)
IL (1) IL90958A0 (es)
MC (1) MC2049A1 (es)
MX (1) MX9203632A (es)
NO (1) NO175476C (es)
NZ (1) NZ229928A (es)
PH (1) PH27275A (es)
PT (1) PT91179B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273986A (en) * 1992-07-02 1993-12-28 Hoffmann-La Roche Inc. Cycloalkylthiazoles
EP0643045B1 (de) * 1993-09-10 2000-03-08 Novartis AG Chinolin-Verbindungen als Leukotriene Antagonisten
US5508408A (en) * 1993-09-10 1996-04-16 Ciba-Geigy Corporation Quinoline compound
WO1996008479A1 (en) * 1994-09-13 1996-03-21 F. Hoffmann-La Roche Ag A process of making (e)-4-[3-[2-(4-cycloalkyl-2-thiazolyl)ethenyl]phenyl]amino-2,2-alkyldiyl-4-oxobutanoic acid
WO1996027592A1 (en) * 1995-03-03 1996-09-12 F. Hoffmann-La Roche Ag Polymorphic b form of (e)-4-[[3-[2-(4-cyclobutyl-2-thiazolyl)ethenyl]phenyl]amino]-2,2-diethyl-4-oxobutanoic acid
AU5347496A (en) * 1995-04-21 1996-11-07 Daiichi Pharmaceutical Co., Ltd. Ethynylthiazole derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62142168A (ja) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤

Also Published As

Publication number Publication date
FI93953B (fi) 1995-03-15
KR900001665A (ko) 1990-02-27
KR960010352B1 (ko) 1996-07-30
JPH0737454B2 (ja) 1995-04-26
HU211268A9 (en) 1995-11-28
HU203087B (en) 1991-05-28
MX9203632A (es) 1992-07-01
MC2049A1 (fr) 1990-07-17
EP0355353A2 (en) 1990-02-28
PH27275A (en) 1993-05-04
DK350989D0 (da) 1989-07-14
FI893434A0 (fi) 1989-07-14
NO892914D0 (no) 1989-07-14
FI93953C (fi) 1995-06-26
BG60765B2 (bg) 1996-02-29
PT91179B (pt) 1995-03-01
CS417291A3 (en) 1992-09-16
DE68913856D1 (de) 1994-04-21
HUT52489A (en) 1990-07-28
AU3828089A (en) 1990-01-18
PT91179A (pt) 1990-02-08
DE68913856T2 (de) 1994-10-20
FI893434A (fi) 1990-01-16
CA1333906C (en) 1995-01-10
IL90958A0 (en) 1990-02-09
AR247737A1 (es) 1995-03-31
NO175476B (no) 1994-07-11
NO175476C (no) 1994-10-19
IE892294L (en) 1990-01-15
JPH0269468A (ja) 1990-03-08
EP0355353A3 (en) 1990-03-07
NZ229928A (en) 1992-08-26
DK350989A (da) 1990-01-16
IE64011B1 (en) 1995-06-28
AU626308B2 (en) 1992-07-30
EP0355353B1 (en) 1994-03-16
NO892914L (no) 1990-01-16

Similar Documents

Publication Publication Date Title
ES2166379T3 (es) 2-aminotetralinas sustituidas.
ES2152444T3 (es) Derivados de acido benzazepin-, benzoxazepin- y benzotiazepin-n-acetico, asi como procedimiento para su preparacion y medicamentos que contienen a estos compuestos.
ES2055056T3 (es) Derivados de pirimidopirimidina.
ES2075082T3 (es) Derivados de isoquinolina para el tratamiento del glaucoma o hipertension ocular.
ES2058040T3 (es) Colorante para teñir el cabello con un contenido en derivados del amino-pirazol y nuevos derivados del pirazol.
ES2140391T3 (es) Derivados de dialcoxi-piridinil-bencimidazol, procedimiento para su preparacion y su uso farmaceutico.
ES2086371T3 (es) 1,3-oxatiolanos sustituidos con propiedades antiviricas.
ES2031841T3 (es) Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona.
ES2260933T3 (es) Derivados del acido de tiazolina.
ES2028857T3 (es) Procedimiento para la preparacion de derivados de amino-tiazol y amino-oxazol.
ES2149468T3 (es) Derivados de radicicol.
ES2118333T3 (es) Derivados del acido naftilacetico como agonistas y antagonistas de pgez.
ES2052825T3 (es) Derivados de cicloalquiltiazol.
ES2164366T3 (es) Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales.
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
PA8458301A1 (es) 2-aminopiridinas con sustituyentes alcoxi ramificados
ES2056146T3 (es) Monopersulfatos de acidos amino-(poli)percarboxilicos.
ES2098109T3 (es) Derivados de 1,2,3,4-tetrahidronaftaleno, de cromano y de tiocromano como agentes antitromboticos.
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2109988T3 (es) Derivados cefalosporinicos.
ES2185797T3 (es) Nitronas ciclicas y composiciones farmaceuticas que las contienen.
AR027578A1 (es) Derivados de indano
ES2059677T3 (es) 1,2,3,4-tetrahidro-1,9-acridindiaminas, un procedimiento para su preparacion y su uso como medicamentos.
CO5170499A1 (es) 1,2,3,4,5, 6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos con n-(5-fenil-tetrahidrofuranil)metilo y n-(6-fenil-tetrahidropiranil)metilo; procedimientos para prepararlos y su empleo como composiciones farmaceuticas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 355353

Country of ref document: ES